CYP2E1 and metabolic dysfunction-associated steatohepatitis: One recent study suggested a link between CYP2E1-333A > T and NASH, the authors showed increased inflammation and NASH in patient biopsies with the TA allele, largely mediated by a small increase in interferon-inducible protein 10 [15].